共 50 条
- [5] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 17
- [7] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study HEADACHE, 2021, 61 : 117 - 118
- [9] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine HEADACHE, 2021, 61 (04): : 653 - 661
- [10] Long-term safety and tolerability of erenumab: Three-plus year results from an ongoing open-label extension study in episodic migraine JOURNAL OF HEADACHE AND PAIN, 2018, 19